Video Library

Growthpoint Boss Norbert Sasse is in the C-SUITE

Growthpoint Boss Norbert Sasse is in the C-SUITE The Future of Work & leadership in uncertainty The Property sector has been hard hit over COVID-19 and strength of balance sheet has been an imperative as tenants have come under pressure especially in the hospitality and leisure industry. Growthpoint's crown jewels, The V&A Waterfront, has understandably been hard hit. Norbert Sasse weighs in on managing under pressure with lack of visibility and he also discusses the Future of Work and where the needle will...

Vodacom’s Shameel Joosub is in the C-SUITE

Telkom is intentionally delaying the release of spectrum. Vodacom's Shameel Joosub is in the C-SUITE In March of this year South Africa's long awaited plan to sell more high speed internet spectrum was thrown into doubt after Telkom won a court ruling suspending the process there is still no clarity on the way forward. Vodacom's Group CEO Shameel Joosub says that this has been Telkom's modus operandi for years. The bottom line is that South African consumers stand to lose as lower data...

Seelan Gobalsamy, CEO of Omnia Holdings is in the C-SUITE

Seelan Gobalsamy the CEO of Omnia Holdings is in the C-SUITE talking about the company's A+ turnaround. Man I love it when a plan comes together and the story of Omnia Holdings is exactly that. The diversified chemicals group has been on a two year turnaround journey which has just seen R1 billion rand in dividends being handed back to investors. The group reported its full year results in mid June for the 12 months to end of March 2021. With Omnia's...

Peter Armitage CEO Anchor Capital weighs in exclusively on Naspers Prosus and Tencent in the C-SUITE

Peter Armitage, CEO of Anchor Capital, weighs in exclusively on Naspers Prosus and Tencent in the C-SUITE Naspers and Prosus make up more than 20% of the South African All Share Index. Within Naspers and Prosus 82% of the net asset value is in Tencent. Tencent is the biggest listed company in China and the company is currently around 40% off it's highs. On balance Anchor Capital is of the view that shareholders, risk profile dependent, should hold fast in the face...

Biggest SA Medical Cannabis Clinical Trial Underway – Dr Shiksha Gallow is on The Business of Health

Biggest SA Medical Cannabis Clinical Trial Underway Dr Shiksha Gallow is on The Business of Health BioData is conducting a 12 month study to examine the difference in the quality of life and effects on chronic pain levels of participating patients by using medical cannabis as an alternative to traditional opioid use. It's being called South Africa's first real world study of medical cannabis involving 1000 participants whose medical cannabis use will be observed over a period of time. The trial is expected to...

Introducing South Africa’s NEW Finance Minister Enoch Godongwana – The Business of Money

Introducing South Africa's NEW Finance Minister Enoch Godongwana The Business of Money Two of South Africa's top economists come out in full support of South Africa's new Finance Minister, Enoch Godongwana, despite the media's attention on his alleged sketchy past connecting him to a high profile pension scam in 2012. The matter was covered extensively at the time by South Africa's reputable Mail & Guardian. Godongwana is seen as the party guru on economics, he is said to be in favour of allowing...

If you cannot control your emotions, you cannot control your money -Buffett

The Business of Money - 30 July 2021 If you cannot control your emotions, you cannot control your money -Buffett As always we assemble the experts to help you make the best investment decisions. In this edition we talk Chinese regulations and the impact on Tencent, Naspers, and Prosus. We discuss the fact that US Tech earnings dominate with Amazon in focus. We also talk Anglo American. Stocks of Interest from our panel: Apple, Microsoft, Merafe, Alphamin, Truworths, and Massmart. Watch all episodes of...

Recently launched Organon is the only company of its size focused exclusively on women’s health.

Recently launched Organon is the only company of its size focused exclusively on women's health. With an international footprint that serves people in more than 140 markets, Organon’s mission is to deliver impactful medicines and solutions for healthcare issues facing women in Sub-Saharan Africa. “As a new healthcare company in South Africa our focus is on listening to South African women’s healthcare needs, and develop solutions tailored to their needs. With our global reach and local mindset, we know there is much...

Where are we in South Africa a week after the rioting and looting

Where are we in South Africa a week after the rioting and looting This week in The Business of Money The South African Reserve Bank keeps interest rates on hold and points to a gloomy growth outlook for the country. Commodities continue to rally with great updates from BHP Billiton and Anglo American but the big question is when do you get out of commodities? US earnings are exceeding expectations which augers well for the global economy. We gather the experts to help...

Biodx – The First South African biotech to achieve EU Biocidal Registration – The Business of Health

Biodx - The First South African biotech to achieve EU Biocidal Registration The Business of Health At the end of a very long, very expensive five years of testing and following a rigorous, strict application process, Biodx has finally achieved EU registration* for their b bioactive™ (DECONT-X™) disinfectant technology. "In a world where everyone is talking about a sustainable future, we’re actually working to create it." - Burt Rodrigues, CEO of Biodx Watch more episodes of The Business Of Health here.